Device Trial Radar · NCT06037850
Clinical Trial of Orthokeratology Lens (MCOK-01)
Last checked: Nov 20, 2026Latest source record: Feb 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
390
Actual
Start
Jul 29, 2022
Primary completion
Oct 31, 2024
Study completion Oct 31, 2024
Sponsor
- Lead sponsor
- Menicon Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 14, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 6 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A prospective, multicenter, randomized, controlled clinical trial of orthokeratology lens
Conditions
- Myopia
Interventions
Test orthokeratology lensDevice
Randomized to test orthokeratology lens worn during sleep every night
Control orthokeratology lensDevice
Randomized to control orthokeratology lens worn during sleep every night
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual acuityTime frame: 1 year
- Axial lengthTime frame: 1 year
- RefractionTime frame: 1 year
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
I&VISION Research Centre
Singapore, Singapore
Myopia Specialist Centre
Singapore, Singapore
Stan Isaacs
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.